DSGN (Design Corp) Earnings per share for the trailing year

Public company logo of Design Pharma (DSGN)

The share price history of Design Therapeutics (DSGN) on the GURU.Markets platform, where the current figure is -1.40, is driven by management's focus on correcting gene expression and strict adherence to ethics. Robust patent protection and unique platforms for combating severe ailments shield the business from price wars. In the future, the use of third-party manufacturing plants will allow the company to expand therapy without incurring capital expenditure costs.

DSGN (designtx.com) Net earnings per share (EPS TTM) history from 02/11/2024 to 11/16/2026

DSGN (Design Therapeutics): analytical breakdowns and indicator data

- share price and consensus valuation forecast:
Fundamental company valuation:DSGN - Design Therapeutics Inc
Core merchandise of Design Corp

Design Therapeutics specializes in developing DNA-based drugs through deep integration with biotechnological laboratories. This indicator measures the percentage change in net earnings per share over a rolling year, reflecting the pace of capital generation. For an investor, this is a key marker of R&D strategy effectiveness and the company's potential attractiveness for M&A transactions. Positive year-over-year EPS growth over the rolling period confirms the resilience of the business model.

Competitor analysis

Earnings per share for the trailing year TEM (Tempus AI Inc)|QGEN (Qiagen Group) - Net earnings per share for the last 12 months|Earnings per one share for the last 12 months IONS (Ionis Pharma)|Earnings per share for the last twelve months Repligen|Earnings per share for the last twelve months RNA|Net earnings per share (EPS TTM) CRSP|Earnings per share for the last twelve months WGS (GeneDx)|Ultragenyx Pharmaceutical - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Beam Tx BEAM|Sarepta Therapeutics - Net earnings per share (EPS TTM)|Twist Bioscience (TWST) - Net earnings per share for the last 12 months|TXG: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Intellia Therapeutics Inc (NTLA)|STOK (stoketherapeutics.com) - Net earnings per share (EPS TTM)|BLFS (BioLife Corp) - Earnings per share for the last four quarters|Earnings per share for the last twelve months Wave Life Sciences Ltd. (WVE)|Earnings per share for the last four quarters MAZE|sionnatx.com - Net earnings per share for the last 12 months|Earnings per share for the trailing year PRME|TSHA - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months uniQure Corp|meiragtx.com (MGTX) - Earnings per share for the last twelve months|Earnings per share for the last 12 months RGNX|Net earnings per share for the last 12 months SLDB|Net earnings per share (EPS TTM) Ocugen Inc|Earnings per share for the last twelve months PacBio Corp (PACB)|Net earnings per share for the last four quarters Benitec Corp|Net earnings per share (EPS TTM) RCKT (Rocket Corp)|FDMT - Net earnings per share for the last 12 months|Lexeo - Net earnings per share (EPS TTM)|KRRO - Net earnings per share (EPS TTM)|EDIT: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months SLN|Net earnings per share for the last 12 months PRQR|Net earnings per one share for the last twelve months Codexis CDXS|Earnings per share for the last twelve months Sangamo BioSciences (SGMO)|Net earnings per share (EPS TTM) Nautilus Biotechnology Inc (NAUT)|Net earnings per share (EPS TTM) MGX (Metagenomi Inc.)|Precision BioSciences - Earnings per share for the last twelve months|generationbio.com - Net earnings per share (EPS TTM)|BOLD: Earnings per share for the last twelve months|XCUR (Exicure Corp) - Net earnings per share for the last 12 months|Earnings per share for the last 12 months IMNN|Earnings per share for the last twelve months RXi Pharmaceuticals|Net earnings per share (EPS TTM) mustangbio.com|Net earnings per share (EPS TTM) RNAZ|Earnings per share for the last twelve months BNGO (Bionano Genomics)|Earnings per share for the last twelve months Applied DNA Sciences APDN|Net earnings per share for the last four quarters bluebird bio Inc. (BLUE)|IPA - Earnings per share for the last twelve months|Earnings per share for the trailing year OMGA (Omega Therapeutics)|OMIC: Net earnings per share (EPS TTM)|RGLS (Regulus Therapeutics Inc.) - Earnings per share for the last twelve months|Earnings per share for the last twelve months Syros Pharmaceuticals Inc.|Telesis Bio Inc. (TBIO) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months traconpharma.com (TCON)|Earnings per share for the last four quarters UBX